Related Experiment Videos
Genetic basis of clinical catecholamine disorders
Emily M Garland1, Maureen K Hahn, Terry P Ketch
1Department of Pharmacology, Autonomic Dysfunction Center, Department of Medicine, Department of Neurology, Vanderbilt University, Nashville, Tennessee 37232, USA.
Annals of the New York Academy of Sciences
|November 20, 2002
Summary
Genetic defects in dopamine-beta-hydroxylase (DBH) and norepinephrine transporter (NET) cause autonomic disorders like orthostatic hypotension. Identifying these genetic causes is key to developing effective treatments for blood pressure regulation.
Area of Science:
- Neuroscience
- Genetics
- Cardiology
Background:
- Norepinephrine and epinephrine are vital for blood pressure regulation.
- Autonomic disorders can stem from genetic abnormalities in the noradrenergic pathway.
Observation:
- Two syndromes linked to genetic defects in the noradrenergic pathway were characterized.
- One syndrome involved dopamine-beta-hydroxylase (DBH) deficiency, leading to undetectable norepinephrine and epinephrine levels.
- Another syndrome investigated abnormal norepinephrine transporter (NET) function in orthostatic intolerance.
Findings:
- DBH deficiency patients had mutations affecting DBH protein expression and function.
- A patient with orthostatic intolerance exhibited impaired NET function due to a specific mutation, reducing activity by over 98%.
- Genetic mutations were identified in both DBH deficiency and orthostatic intolerance.
Implications:
- Discovering genetic causes for DBH deficiency and orthostatic intolerance provides a foundation for understanding other autonomic disorders.
- These findings pave the way for designing targeted and more effective therapeutic interventions for patients with autonomic dysfunction.